Alternating HAIC and Systemic Chemotherapy With or Without Adebrelimab and Apatinib for Unresectable Biliary Tract Cancer

NCT07569679 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

124

Enrollment

OTHER

Sponsor class

Conditions

Biliary Tract Cancer

Interventions

PROCEDURE: HAIC
DRUG: Gemcitabine plus Cisplatin
DRUG: Adebrelimab
DRUG: Apatinib

Sponsor

Air Force Military Medical University, China